genedrive plc (LON:GDR – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 1.98 ($0.03) and traded as low as GBX 1.50 ($0.02). genedrive shares last traded at GBX 1.50 ($0.02), with a volume of 3,571,504 shares.
genedrive Trading Up 0.7 %
The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35. The firm has a market cap of £8.57 million, a PE ratio of -0.42 and a beta of -0.04. The stock’s fifty day simple moving average is GBX 1.98 and its two-hundred day simple moving average is GBX 2.14.
genedrive (LON:GDR – Get Free Report) last released its quarterly earnings data on Thursday, March 27th. The company reported GBX (0.40) (($0.01)) earnings per share for the quarter. genedrive had a negative net margin of 1,412.18% and a negative return on equity of 191.22%. On average, sell-side analysts forecast that genedrive plc will post 209.9999867 EPS for the current fiscal year.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Featured Stories
- Five stocks we like better than genedrive
- Find and Profitably Trade Stocks at 52-Week Lows
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Energy and Oil Stocks Explained
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What Are Earnings Reports?
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.